Advertisement
Journal of Ovarian Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
The Journal of Ovarian Research invites you to join our team of reviewers in assessing manuscripts. For consideration, please send your CV to dana.dovey@biomedcentral.com.
Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer
Ovarian cancer is the leading cause of gynecologic cancer death in the United States despite effective first-line systemic chemotherapy. Cancer stem cells (CSCs) retain the ability to self-renew and proliferate and may be a means of harboring disease that evades standard treatment strategies. We previously performed a high-throughput screen to assess differential protein expression in ovarian CSCs compared to non-CSCs and observed that Thy-1 was more highly expressed in CSCs. Our primary aim was to validate Thy-1 (CD90) as a cancer stem cell (CSC) marker in epithelial ovarian cancer (EOC), correlate with clinical outcomes, and assess as a potential therapeutic target.
Journal of Ovarian Research is an open access, peer reviewed, online journal that aims to provide a forum for high-quality basic and clinical research on ovarian function, abnormalities, and cancer. The journal focuses on research that provides new insights into ovarian functions as well as prevention and treatment of diseases afflicting the organ.
Topical areas include, but are not restricted to:
Journal of Ovarian Research is affiliated with the CROWN initiative, Core Outcomes in Women’s Health. CROWN is an international initiative, led by journal editors, to harmonise outcome reporting in women’s health research. We are coming together to address the widespread, unwarranted variation in reporting of outcomes. CROWN’s main aim is to encourage researchers to report core outcome sets for key conditions in women’s health.
Sham S Kakar, University of Louisville, USA
Benjamin K Tsang, University of Ottawa, Canada
Advertisement
Speed
67 days to first decision for reviewed manuscripts only
58 days to first decision for all manuscripts
114 days from submission to acceptance
14 days from acceptance to publication
Citation Impact
2.469 - 2-year Impact Factor
2.717 - 5-year Impact Factor
0.936 - Source Normalized Impact per Paper (SNIP)
0.938 - SCImago Journal Rank (SJR)
Usage
256,121 Downloads
94 Altmetric Mentions
Advertisement
